Standard Biotools

LABNasdaq United States Industrials Biotechnology: Laboratory Analytical Instruments

Market cap

$245.323 M

$0.62 +0.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Standard Biotools (LAB) has a market capitalization of $245.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$85.3M

#2539 by revenue

Earnings

-$74.9M

Loss-making

Shares outstanding

394,790,441

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →

#11Cytek BiosciencesCTKB$704.3M
#12Nautilus BiotechnologyNAUT$277.0M
#13Standard BiotoolsLAB$245.3M
#14QuanterixQTRX$130.1M
#15SeerSEER$90.5M

What if Standard Biotools were worth as much as…

Open the what-if tool →

Gold $28.2T

$71,523.70

Per share 115,101× higher

Bitcoin $1.53T

$3,870.02

Per share 6,228× higher

Apple $5.02T

$12,704.92

Per share 20,446× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Standard Biotools are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.